cgp 54626 has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 1 studies
Studies (cgp 54626) | Trials (cgp 54626) | Recent Studies (post-2010) (cgp 54626) | Studies (6-methyl-2-(phenylethynyl)pyridine) | Trials (6-methyl-2-(phenylethynyl)pyridine) | Recent Studies (post-2010) (6-methyl-2-(phenylethynyl)pyridine) |
---|---|---|---|---|---|
57 | 0 | 16 | 543 | 0 | 185 |
Protein | Taxonomy | cgp 54626 (IC50) | 6-methyl-2-(phenylethynyl)pyridine (IC50) |
---|---|---|---|
Luciferin 4-monooxygenase | Photinus pyralis (common eastern firefly) | 6.2333 | |
Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | 0.0129 | |
Metabotropic glutamate receptor 5 | Homo sapiens (human) | 0.0199 | |
Amine oxidase [flavin-containing] A | Mus musculus (house mouse) | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bray, SM; Chang, S; He, C; Jin, P; Li, Z; Warren, ST; Zarnescu, DC | 1 |
1 other study(ies) available for cgp 54626 and 6-methyl-2-(phenylethynyl)pyridine
Article | Year |
---|---|
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila.
Topics: Animals; Disease Models, Animal; Drosophila; Drosophila Proteins; Drug Evaluation, Preclinical; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; gamma-Aminobutyric Acid; Glutamic Acid; Male; Molecular Weight; Mutation; Phenotype; Pyridines; RNA, Messenger; Small Molecule Libraries | 2008 |